0001209191-21-000519.txt : 20210104 0001209191-21-000519.hdr.sgml : 20210104 20210104190012 ACCESSION NUMBER: 0001209191-21-000519 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210101 FILED AS OF DATE: 20210104 DATE AS OF CHANGE: 20210104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chen Leon CENTRAL INDEX KEY: 0001752432 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38707 FILM NUMBER: 21503349 MAIL ADDRESS: STREET 1: 610 MAIN STREET STREET 2: 3RD FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LogicBio Therapeutics, Inc. CENTRAL INDEX KEY: 0001664106 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 471514975 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 65 HAYDEN AVE STREET 2: 2ND FLOOR CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617-245-0399 MAIL ADDRESS: STREET 1: 65 HAYDEN AVE STREET 2: 2ND FLOOR CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-01 0 0001664106 LogicBio Therapeutics, Inc. LOGC 0001752432 Chen Leon 65 HAYDEN AVENUE, FLOOR 2 LEXINGTON MA 02421 1 0 0 0 Common Stock 2021-01-01 4 M 0 3298 A 3298 D Restricted Stock Units 2021-01-01 4 M 0 3298 0.00 D Common Stock 3298 0 D Each restricted stock unit ("RSU") represented a contingent right to receive one share of common stock of LogicBio Therapeutics, Inc. (the "Company"). All of the RSUs vested on January 1, 2021, subject to the terms and conditions of the award and the Company's 2018 Plan. Frederic Chereau, as Attorney-in-Fact 2021-01-04